Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Hepatocellular Carcinoma (HCC)”

1,185 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,185 results

Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more
Exelixis 1,314
Testing effectiveness (Phase 2)Looking for participantsNCT05652920
What this trial is testing

Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC

Who this might be right for
Hepatocellular Carcinoma
OriCell Therapeutics Co., Ltd. 105
Not applicableNot Yet RecruitingNCT07645742
What this trial is testing

Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors

Who this might be right for
Cancer (Advanced Stage)
West Virginia University 90
Early research (Phase 1)Looking for participantsNCT06374485
What this trial is testing

Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment

Who this might be right for
Advanced Hepatocellular Carcinoma
Lee's Pharmaceutical Limited 18
Testing effectiveness (Phase 2)Looking for participantsNCT06309485
What this trial is testing

Phase 2 Study of WGI-0301 for Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Zhejiang Haichang Biotech Co., Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT03114085
What this trial is testing

Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital of Guangxi Medical University 170
Testing effectiveness (Phase 2)Study completedNCT00519688
What this trial is testing

UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 44
Testing effectiveness (Phase 2)Looking for participantsNCT06923761
What this trial is testing

EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)

Who this might be right for
Advanced Solid Malignancy
Grey Wolf Therapeutics 300
Not applicableUnknownNCT05981066
What this trial is testing

A Clinical Study of mRNA Vaccine (ABOR2014/IPM511) in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Peking Union Medical College Hospital 48
Testing effectiveness (Phase 2)Study completedNCT01900002
What this trial is testing

Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaRecurrent Adult Hepatocellular Carcinoma+8 more
M.D. Anderson Cancer Center 40
Early research (Phase 1)Ended earlyNCT04099277
What this trial is testing

LY3435151 in Participants With Solid Tumors

Who this might be right for
Solid TumorTriple-negative Breast CancerGastric Adenocarcinoma+6 more
Eli Lilly and Company 2
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05195294
What this trial is testing

Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC

Who this might be right for
Hepatocellular CarcinomaLiver Cancer, AdultLiver Cell Carcinoma
Lion TCR Pte. Ltd. 55
Not applicableNot Yet RecruitingNCT06971237
What this trial is testing

SIRT and Peri-immunotherapy : a New Concept

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC), Classified as BCLC Stage B or C, Treated With a Combination of Selective Internal Radiation Therapy
Assistance Publique - Hôpitaux de Paris 60
Early research (Phase 1)Study completedNCT01008566
What this trial is testing

Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver Carcinoma+1 more
National Cancer Institute (NCI) 21
Not applicableNot Yet RecruitingNCT07321067
What this trial is testing

Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Ahmed Karam Helmy 75
Testing effectiveness (Phase 2)Looking for participantsNCT03539822
What this trial is testing

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

Who this might be right for
Gastric CancerEsophageal AdenocarcinomaHepatocellular Carcinoma+1 more
Anwaar Saeed 117
Not applicableStudy completedNCT04568330
What this trial is testing

Prevention of Hand-foot Skin Reaction

Who this might be right for
Hepatocellular Carcinoma
Taipei Veterans General Hospital, Taiwan 129
Large-scale testing (Phase 3)Ended earlyNCT01108705
What this trial is testing

Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment

Who this might be right for
Carcinoma, Hepatocellular
Bristol-Myers Squibb 87
Testing effectiveness (Phase 2)Study completedNCT01210495
What this trial is testing

Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Pfizer 224
Load More Results